January 18th 2026
Patients with proinflammatory, pro-oxidative diets may face accelerated biological aging and increased skin cancer risk.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Leveraging Biologics and Immunotherapies in the Management of Food Allergies
1.5 Credits / Immunology, Allergy
View More
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
1.5 Credits / Immunology, Pulmonology
View More
Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden
1.5 Credits / Immunology
View More
Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition
1.5 Credits / Gastroenterology, Immunology
View More
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
1.5 Credits / Gastroenterology, Immunology
View More
The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care
1.0 Credit / Immunology, Nephrology
View More
The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes
1.0 Credit / Immunology, Nephrology
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape
1.0 Credit / Immunology, Rare Diseases
View More
Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape
1.0 Credits / Dermatology, Immunology
View More
Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes
2.0 Credits / Immunology, Rare Diseases, Hematology
View More
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
1.0 Credit / Immunology, Neurology, Rare Diseases
View More
IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems
1.0 Credits / Dermatology, Immunology
View More
The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies
1.0 Credit / Immunology, Nephrology
View More
RA-Specific Physical Activity Resources Provide Guidance but Need Improvement
February 26th 2025An extensive library of physical activity resources will better support the different needs, capabilities, and considerations of patients with rheumatoid arthritis (RA), according to the researchers.
Read More
Clinical Insights, Strategies for Delivering Equitable Psoriatic Arthritis Care
February 20th 2025Recognizing psoriasis and psoriatic arthritis (PsA) in non-White patients is the first step toward providing more equitable care for those of all backgrounds with PsA, according to Rebecca Haberman, MD, of NYU Langone Health.
Watch
Challenging Perceptions: Exploring Racial, Ethnic Disparities in Psoriatic Arthritis
February 17th 2025Although psoriatic arthritis may be more prevalent in White patients, Rebecca Haberman, MD, of NYU Langone Health, emphasizes that the disease affects those across diverse racial and ethnic backgrounds.
Watch
Higher Psoriatic Arthritis Disease Burden Found Among Hispanic, Non-White Patients
February 4th 2025Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and treatment outcomes.
Read More
Mind the Gap: Patient-Reported PsA Impact Scores, Physician Treatment Decisions Misaligned
January 23rd 2025While higher patient-reported Psoriatic Arthritis (PsA) Impact of Disease questionnaire (PsAID-12) scores were associated with treatment escalation, physicians primarily relied on clinical assessments when making treatment decisions.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More
Nurse-Led Care Improves Disease Activity in Rheumatoid Arthritis
January 8th 2025Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, delivering comparable outcomes to rheumatologist-led care and usual care while easing health care burdens.
Read More
Male Patients With Eosinophilic Esophagitis Face Higher Complication Rates
January 6th 2025Compared with female patients, male patients with eosinophilic esophagitis have higher rates of complications, including esophageal obstruction, food impaction, and rupture, highlighting potential gender differences in disease severity.
Read More
Dr Raj Chovatiya Summarizes Clinical Implications of Type 2 Inflammation
November 24th 2023Raj Chovatiya, MD, PhD, assistant professor of dermatology at Northwestern University's Feinberg School of Medicine, discussed type 2 inflammation in atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.
Watch
Upadacitinib Demonstrates Efficacy in RA Treatment Regardless of Patient’s Baseline CRP Levels
November 22nd 2023In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.
Read More
Posters Presented at ACG 2023 Explore Pediatric Patient EoE Risk, Allergic Comorbidities Prevalence
October 26th 2023Posters presented at the American College of Gastroenterology's (ACG's) 2023 Annual Scientific Meeting examined potential environmental risks of eosinophilic esophagitis (EoE) on the pediatric population, as well as the presence of allergic comorbidities in children diagnosed with EoE.
Read More